Iterum Therapeutics plc (ITRM)
NASDAQ: ITRM · Real-Time Price · USD
1.770
+0.140 (8.59%)
Nov 21, 2024, 3:47 PM EST - Market open

Iterum Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Net Income
--38.37-44.43-91.56-52.01-103.13
Upgrade
Depreciation & Amortization
-1.751.82.10.160.15
Upgrade
Other Amortization
-2.342.344.110.930.36
Upgrade
Loss (Gain) From Sale of Investments
--1.15-0.180.64--0.13
Upgrade
Stock-Based Compensation
-0.7822.114.322.762.17
Upgrade
Other Operating Activities
--7.45-2.4165.018.190.75
Upgrade
Change in Accounts Payable
-2.221.90.06-14.6711.45
Upgrade
Change in Income Taxes
-0.27-0.510.27-0.120.12
Upgrade
Change in Other Net Operating Assets
-0.270.93-0.77-9.776.33
Upgrade
Operating Cash Flow
--39.33-18.47-15.84-54.53-81.92
Upgrade
Capital Expenditures
--0.01-0.06-0.06-0.01-0.02
Upgrade
Investment in Securities
-23.3514.02-54.53-40.13
Upgrade
Investing Cash Flow
-23.3413.96-54.6-0.0140.1
Upgrade
Long-Term Debt Issued
----0.74-
Upgrade
Long-Term Debt Repaid
---2.25-6.52-6.23-1.03
Upgrade
Net Debt Issued (Repaid)
---2.25-6.52-5.49-1.03
Upgrade
Issuance of Common Stock
-1.030.4389.6458.373.1
Upgrade
Other Financing Activities
----11.59-
Upgrade
Financing Cash Flow
-1.03-1.8283.1364.482.06
Upgrade
Foreign Exchange Rate Adjustments
--0.06-0.050-0.01-0.02
Upgrade
Net Cash Flow
--15.02-6.3812.699.93-39.78
Upgrade
Free Cash Flow
--39.34-18.54-15.9-54.54-81.95
Upgrade
Free Cash Flow Margin
------221475.68%
Upgrade
Free Cash Flow Per Share
--3.04-1.51-1.46-34.07-84.67
Upgrade
Cash Interest Paid
--0.020.4211.4
Upgrade
Cash Income Tax Paid
-0.40.820.440.120.41
Upgrade
Levered Free Cash Flow
--22.38-14.02-28.78-8.72-41.11
Upgrade
Unlevered Free Cash Flow
--22.75-14.37-30.04-11.96-40.37
Upgrade
Change in Net Working Capital
--4.41.8721.07-5.21-21.09
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.